St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Alex Generous, PhD
Senior Scientific Writer
Alex Generous, PhD, is a Senior Scientific Writer in the Strategic Communications, Education and Outreach Department at St. Jude.
Stories by Alex Generous
Nutrition is a key ingredient for defense against infectious diseases in kids with cancer
Addressing vitamin deficiencies could improve cancer care.
Quantum computing makes waves in drug discovery
Learn how quantum computing is being used at St. Jude.
A curative gene therapy for Diamond-Blackfan anemia nears the clinic
Find how St. Jude researchers are pushing forward a potential cure for DBA.
Space-age lessons could protect childhood cancer survivors’ bone health
Identifying how to help survivors that lose bone density during treatment.
St. Jude scientists do more with less using PeCan-Seq liquid biopsy
Novel plasma test shows promise.
High-performance computing team powers scientific discovery at St. Jude
Democratized access to computational power fuels research.
The ticking ‘epigenetic’ clock measures true biological age
Dive into research on the ‘epigenetic clock’ and learn how understanding it can help childhood cancer survivors.
Global effort improves patients’ quality of life through palliative care
St. Jude is collaborating to expand access to palliative care worldwide.
Blinatumomab added to chemotherapy improves survival for adults with acute lymphoblastic leukemia
St. Jude scientists contributed to a phase 3 clinical trial showing that blinatumomab added to chemotherapy is effective against leukemia in adults.
Universal pneumonia vaccination is the result of decades of research
Through decades of research Elaine Tuomanen, MD, made crucial contributions to the creation of the first universal vaccine for pneumonia – now in clinical trials.